The global Imbruvica market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Imbruvica is a small molecule drug that binds permanently to a protein, Bruton's tyrosine kinase (BTK), that is important in B cells; the drug is used to treat B cell cancers like mantle cell lymphoma, chronic lymphocytic leukemia, and Waldenstrm's macroglobulinemia.
This report aims to provide a comprehensive presentation of the global market for Imbruvica, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Imbruvica. This report contains market size and forecasts of Imbruvica in global, including the following market information:
- Global Imbruvica Market Revenue, 2018-2023, 2024-2030, ($ millions)
- Global top five companies in 2022 (%)
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
5 mg Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Imbruvica include AbbVie (Pharmacyclics), Johnson & Johnson (Janssen Biotech) and SP Laboratories, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Imbruvica companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Imbruvica Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Imbruvica Market Segment Percentages, by Type, 2022 (%)
Global Imbruvica Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Imbruvica Market Segment Percentages, by Application, 2022 (%)
- Mantle Cell Lymphoma
- Chronic Lymphocytic Leukemia
- Waldenstrm's Macroglobulinemia
- Relapsed/Refractory Marginal Zone Lymphoma
- Chronic Graft-Versus-Host-Disease
Global Imbruvica Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Imbruvica Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Imbruvica revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies Imbruvica revenues share in global market, 2022 (%)
Key players include:
- AbbVie (Pharmacyclics)
- Johnson & Johnson (Janssen Biotech)
- SP Laboratories
Outline of Major Chapters:
Chapter 1: Introduces the definition of Imbruvica, market overview.
Chapter 2: Global Imbruvica market size in revenue.
Chapter 3: Detailed analysis of Imbruvica company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Imbruvica in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Imbruvica Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Imbruvica Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Imbruvica Overall Market Size
2.1 Global Imbruvica Market Size: 2022 VS 2030
2.2 Global Imbruvica Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Imbruvica Players in Global Market
3.2 Top Global Imbruvica Companies Ranked by Revenue
3.3 Global Imbruvica Revenue by Companies
3.4 Top 3 and Top 5 Imbruvica Companies in Global Market, by Revenue in 2022
3.5 Global Companies Imbruvica Product Type
3.6 Tier 1, Tier 2 and Tier 3 Imbruvica Players in Global Market
3.6.1 List of Global Tier 1 Imbruvica Companies
3.6.2 List of Global Tier 2 and Tier 3 Imbruvica Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Imbruvica Market Size Markets, 2022 & 2030
4.1.2 5 mg
4.1.3 10 mg
4.1.4 140 mg
4.2 By Type - Global Imbruvica Revenue & Forecasts
4.2.1 By Type - Global Imbruvica Revenue, 2018-2023
4.2.2 By Type - Global Imbruvica Revenue, 2024-2030
4.2.3 By Type - Global Imbruvica Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Imbruvica Market Size, 2022 & 2030
5.1.2 Mantle Cell Lymphoma
5.1.3 Chronic Lymphocytic Leukemia
5.1.4 Waldenstr?m's Macroglobulinemia
5.1.5 Relapsed/Refractory Marginal Zone Lymphoma
5.1.6 Chronic Graft-Versus-Host-Disease
5.2 By Application - Global Imbruvica Revenue & Forecasts
5.2.1 By Application - Global Imbruvica Revenue, 2018-2023
5.2.2 By Application - Global Imbruvica Revenue, 2024-2030
5.2.3 By Application - Global Imbruvica Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Imbruvica Market Size, 2022 & 2030
6.2 By Region - Global Imbruvica Revenue & Forecasts
6.2.1 By Region - Global Imbruvica Revenue, 2018-2023
6.2.2 By Region - Global Imbruvica Revenue, 2024-2030
6.2.3 By Region - Global Imbruvica Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Imbruvica Revenue, 2018-2030
6.3.2 US Imbruvica Market Size, 2018-2030
6.3.3 Canada Imbruvica Market Size, 2018-2030
6.3.4 Mexico Imbruvica Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Imbruvica Revenue, 2018-2030
6.4.2 Germany Imbruvica Market Size, 2018-2030
6.4.3 France Imbruvica Market Size, 2018-2030
6.4.4 U.K. Imbruvica Market Size, 2018-2030
6.4.5 Italy Imbruvica Market Size, 2018-2030
6.4.6 Russia Imbruvica Market Size, 2018-2030
6.4.7 Nordic Countries Imbruvica Market Size, 2018-2030
6.4.8 Benelux Imbruvica Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Imbruvica Revenue, 2018-2030
6.5.2 China Imbruvica Market Size, 2018-2030
6.5.3 Japan Imbruvica Market Size, 2018-2030
6.5.4 South Korea Imbruvica Market Size, 2018-2030
6.5.5 Southeast Asia Imbruvica Market Size, 2018-2030
6.5.6 India Imbruvica Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Imbruvica Revenue, 2018-2030
6.6.2 Brazil Imbruvica Market Size, 2018-2030
6.6.3 Argentina Imbruvica Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Imbruvica Revenue, 2018-2030
6.7.2 Turkey Imbruvica Market Size, 2018-2030
6.7.3 Israel Imbruvica Market Size, 2018-2030
6.7.4 Saudi Arabia Imbruvica Market Size, 2018-2030
6.7.5 UAE Imbruvica Market Size, 2018-2030
7 Imbruvica Companies Profiles
7.1 AbbVie (Pharmacyclics)
7.1.1 AbbVie (Pharmacyclics) Company Summary
7.1.2 AbbVie (Pharmacyclics) Business Overview
7.1.3 AbbVie (Pharmacyclics) Imbruvica Major Product Offerings
7.1.4 AbbVie (Pharmacyclics) Imbruvica Revenue in Global Market (2018-2023)
7.1.5 AbbVie (Pharmacyclics) Key News & Latest Developments
7.2 Johnson & Johnson (Janssen Biotech)
7.2.1 Johnson & Johnson (Janssen Biotech) Company Summary
7.2.2 Johnson & Johnson (Janssen Biotech) Business Overview
7.2.3 Johnson & Johnson (Janssen Biotech) Imbruvica Major Product Offerings
7.2.4 Johnson & Johnson (Janssen Biotech) Imbruvica Revenue in Global Market (2018-2023)
7.2.5 Johnson & Johnson (Janssen Biotech) Key News & Latest Developments
7.3 SP Laboratories
7.3.1 SP Laboratories Company Summary
7.3.2 SP Laboratories Business Overview
7.3.3 SP Laboratories Imbruvica Major Product Offerings
7.3.4 SP Laboratories Imbruvica Revenue in Global Market (2018-2023)
7.3.5 SP Laboratories Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Imbruvica Market Opportunities & Trends in Global Market
Table 2. Imbruvica Market Drivers in Global Market
Table 3. Imbruvica Market Restraints in Global Market
Table 4. Key Players of Imbruvica in Global Market
Table 5. Top Imbruvica Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Imbruvica Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Imbruvica Revenue Share by Companies, 2018-2023
Table 8. Global Companies Imbruvica Product Type
Table 9. List of Global Tier 1 Imbruvica Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Imbruvica Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Imbruvica Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Imbruvica Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Imbruvica Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Imbruvica Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Imbruvica Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Imbruvica Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Imbruvica Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Imbruvica Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Imbruvica Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Imbruvica Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Imbruvica Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Imbruvica Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Imbruvica Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Imbruvica Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Imbruvica Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Imbruvica Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Imbruvica Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Imbruvica Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Imbruvica Revenue, (US$, Mn), 2024-2030
Table 30. AbbVie (Pharmacyclics) Company Summary
Table 31. AbbVie (Pharmacyclics) Imbruvica Product Offerings
Table 32. AbbVie (Pharmacyclics) Imbruvica Revenue (US$, Mn) & (2018-2023)
Table 33. AbbVie (Pharmacyclics) Key News & Latest Developments
Table 34. Johnson & Johnson (Janssen Biotech) Company Summary
Table 35. Johnson & Johnson (Janssen Biotech) Imbruvica Product Offerings
Table 36. Johnson & Johnson (Janssen Biotech) Imbruvica Revenue (US$, Mn) & (2018-2023)
Table 37. Johnson & Johnson (Janssen Biotech) Key News & Latest Developments
Table 38. SP Laboratories Company Summary
Table 39. SP Laboratories Imbruvica Product Offerings
Table 40. SP Laboratories Imbruvica Revenue (US$, Mn) & (2018-2023)
Table 41. SP Laboratories Key News & Latest Developments
List of Figures
Figure 1. Imbruvica Segment by Type in 2022
Figure 2. Imbruvica Segment by Application in 2022
Figure 3. Global Imbruvica Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Imbruvica Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Imbruvica Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Imbruvica Revenue in 2022
Figure 8. By Type - Global Imbruvica Revenue Market Share, 2018-2030
Figure 9. By Application - Global Imbruvica Revenue Market Share, 2018-2030
Figure 10. By Type - Global Imbruvica Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Imbruvica Revenue Market Share, 2018-2030
Figure 12. By Application - Global Imbruvica Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Imbruvica Revenue Market Share, 2018-2030
Figure 14. By Region - Global Imbruvica Revenue Market Share, 2018-2030
Figure 15. By Country - North America Imbruvica Revenue Market Share, 2018-2030
Figure 16. US Imbruvica Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Imbruvica Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Imbruvica Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Imbruvica Revenue Market Share, 2018-2030
Figure 20. Germany Imbruvica Revenue, (US$, Mn), 2018-2030
Figure 21. France Imbruvica Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Imbruvica Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Imbruvica Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Imbruvica Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Imbruvica Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Imbruvica Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Imbruvica Revenue Market Share, 2018-2030
Figure 28. China Imbruvica Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Imbruvica Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Imbruvica Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Imbruvica Revenue, (US$, Mn), 2018-2030
Figure 32. India Imbruvica Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Imbruvica Revenue Market Share, 2018-2030
Figure 34. Brazil Imbruvica Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Imbruvica Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Imbruvica Revenue Market Share, 2018-2030
Figure 37. Turkey Imbruvica Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Imbruvica Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Imbruvica Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Imbruvica Revenue, (US$, Mn), 2018-2030
Figure 41. AbbVie (Pharmacyclics) Imbruvica Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Johnson & Johnson (Janssen Biotech) Imbruvica Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. SP Laboratories Imbruvica Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
